Key facts
- Notable investors include 3cubed Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for SuperSenses
- ·The full record, as it builds
Funding rounds
No funding rounds for SuperSenses are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SuperSenses
Developer of at-home sensory testing intended to identify early biomarkers for cognitive health. The company's test conducts an comprehensive assessment of all five senses to evaluate current health status, partners with senior living facilities and healthcare providers to implement preventive brain health programs and provides actionable data, helping physicians and patients implement targeted interventions at early stage to maintain cognitive vitality, boost memory, and safeguard against risks such as loss of independence and dementia.
- Sector
- Healthcare
- HQ
- Marina Del Rey, CA, United States
- Founded
- 2023
- Employees
- 2
- Website
- super-senses.com/
- Ownership
- Privately Held (backing)
SuperSenses doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SuperSenses shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SuperSenses in its N-PORT filings yet. We sweep new filings monthly.